Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients With Acute Coronary Syndrome Undergoing Coronary Stenting After Pretreatment With a High Loading Dose of Clopidogrel (ISAR-REACT-2).
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2008
At a glance
- Drugs Abciximab (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery restenosis; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms ISAR-REACT-2
- 15 Nov 2007 New trial centres added.
- 29 Oct 2005 New trial record.